Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
暂无分享,去创建一个
R. Greil | J. Bergh | M. Gnant | H. Johansson | Y. Brandberg | T. Foukakis | V. Möbus | M. Hellström